While the top players of the over Rs850 billion pharmaceutical business are up
in arms over what they call rampant spread of counterfeit drugs (allegedly 20%
to 25% of total pharmaceutical sales) in the country, enforcement agencies and
some pharmaceutical associations say the situation is not that alarming,
But, they acknowledged that there are areas, which have slowly...